compare Cadence results vs synopsys financials
7/31/2025 09:54am
Cadence Design Systems (CADE) and Synopsys, Inc. (SNPS) demonstrate distinct financial performance metrics within their respective quarters:
1. **Net Income and Growth**:
- Cadence Design Systems reported a net income of $133.22 million for the quarter ending Q1 2025, with a year-over-year growth rate of 14%. This indicates a strong profitability period for Cadence.
- Synopsys, Inc. reported a net income of $345.11 million for the quarter ending Q2 2025, with a year-over-year growth rate of 19%. Synopsys has shown a higher net income and a stronger growth rate compared to Cadence.
|code|Ticker|Name|Date|Net Income|market_code|
|---|---|---|---|---|---|
|CADE|CADE.N|Cadence|2024 Q2|1.37472E8|169|
|SNPS|SNPS.O|Synopsys|2024 Q2|2.89089E8|185|
|CADE|CADE.N|Cadence|2024 Q3|1.36439E8|169|
|SNPS|SNPS.O|Synopsys|2024 Q3|4.04894E8|185|
|CADE|CADE.N|Cadence|2024 Q4|1.32715E8|169|
|SNPS|SNPS.O|Synopsys|2024 Q4|1.09562E9|185|
|CADE|CADE.N|Cadence|2025 Q1|1.33222E8|169|
|SNPS|SNPS.O|Synopsys|2025 Q1|2.97411E8|185|
|code|Ticker|Name|Date|Total Revenue|market_code|
|---|---|---|---|---|---|
|CADE|CADE.N|Cadence|2024 Q2|4.56976E8|169|
|SNPS|SNPS.O|Synopsys|2024 Q2|1.454712E9|185|
|CADE|CADE.N|Cadence|2024 Q3|4.47359E8|169|
|SNPS|SNPS.O|Synopsys|2024 Q3|1.525749E9|185|
|CADE|CADE.N|Cadence|2024 Q4|4.50696E8|169|
|SNPS|SNPS.O|Synopsys|2024 Q4|1.635986E9|185|
|CADE|CADE.N|Cadence|2025 Q1|4.48539E8|169|
|SNPS|SNPS.O|Synopsys|2025 Q1|1.455315E9|185|
|code|Ticker|Name|Date|Diluted EPS|market_code|
|---|---|---|---|---|---|
|CADE|CADE.N|Cadence|2024 Q2|0.733|169|
|SNPS|SNPS.O|Synopsys|2024 Q2|1.88|185|
|CADE|CADE.N|Cadence|2024 Q3|0.72|169|
|SNPS|SNPS.O|Synopsys|2024 Q3|2.61|185|
|SNPS|SNPS.O|Synopsys|2024 Q4|7.14|185|
|CADE|CADE.N|Cadence|2025 Q1|0.7|169|
|SNPS|SNPS.O|Synopsys|2025 Q1|1.89|185|
2. **Total Revenue and Growth**:
- Cadence Design Systems reported total revenues of $448.54 million for the quarter ending Q1 2025, with a year-over-year growth rate of 2%. This suggests a steady revenue growth for Cadence.
- Synopsys, Inc. reported total revenues of $1.6 billion for the quarter ending Q2 2025, with a year-over-year growth rate of 10%. Synopsys has a significantly higher revenue base and a higher growth rate compared to Cadence.
|code|Ticker|Name|Date|Net Income YoY|market_code|
|---|---|---|---|---|---|
|CADE|CADE.N|Cadence|20240630|20.559862489914757|169|
|SNPS|SNPS.O|Synopsys|20240630|7.090624861084358|185|
|CADE|CADE.N|Cadence|20240930|47.36938746854174|169|
|SNPS|SNPS.O|Synopsys|20240930|21.569710708441548|185|
|CADE|CADE.N|Cadence|20241231|-48.77134607664516|169|
|SNPS|SNPS.O|Synopsys|20241231|216.2008109785134|185|
|CADE|CADE.N|Cadence|20250331|13.886371796406161|169|
|SNPS|SNPS.O|Synopsys|20250331|-33.34685471093013|185|
|code|Ticker|Name|Date|Total Revenue YoY|market_code|
|---|---|---|---|---|---|
|CADE|CADE.N|Cadence|20240630|8.75435218745761|169|
|SNPS|SNPS.O|Synopsys|20240630|15.202448002128696|185|
|CADE|CADE.N|Cadence|20240930|11.02124586486131|169|
|SNPS|SNPS.O|Synopsys|20240930|12.652116450948398|185|
|CADE|CADE.N|Cadence|20241231|1847.1874189924827|169|
|SNPS|SNPS.O|Synopsys|20241231|11.490047247378495|185|
|CADE|CADE.N|Cadence|20250331|2.4777584339744205|169|
|SNPS|SNPS.O|Synopsys|20250331|-3.6846065722516843|185|
|code|Ticker|Name|Date|Diluted EPS YoY|market_code|
|---|---|---|---|---|---|
|CADE|CADE.N|Cadence|20240630|20.163934426229506|169|
|SNPS|SNPS.O|Synopsys|20240630|6.818181818181812|185|
|CADE|CADE.N|Cadence|20240930|46.93877551020408|169|
|SNPS|SNPS.O|Synopsys|20240930|20.276497695852534|185|
|SNPS|SNPS.O|Synopsys|20241231|215.92920353982302|185|
|CADE|CADE.N|Cadence|20250331|12.903225806451607|169|
|SNPS|SNPS.O|Synopsys|20250331|-34.60207612456748|185|
In conclusion, while both companies are showing positive growth, Synopsys, Inc. outperforms Cadence Design Systems in terms of both net income and total revenue. This suggests that Synopsys may have a stronger market position or a more effective business strategy in terms of financial performance during the reported periods.
